Science & Enterprise subscription

Follow us on Twitter

  • The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
    about 14 hours ago
  • New post on Science and Enterprise: BARDA to Buy $2B in Covid-19 Vaccines, Therapies https://t.co/LFM1IUr1rN #Science #Business
    about 14 hours ago
  • A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple… https://t.co/0PktfkzyNH
    about 21 hours ago
  • New post on Science and Enterprise: FDA Halts Off-the-Shelf Engineered T-Cell Trial https://t.co/Fbz7IKCgky #Science #Business
    about 21 hours ago
  • If you dig deep into the Science & Enterprise archives, you'll find this site began posting on 6 July 2010, exactly… https://t.co/eGPudMExsK
    about 2 days ago

Please share Science & Enterprise

Dual Antibodies in Trial to Prevent Covid-19 Infections

Global Covid-19

A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infections, while also in a trial as a treatment for the disease. . . . → Read More: Dual Antibodies in Trial to Prevent Covid-19 Infections

Engineered Immune, Stem Cells Studied for HIV Cure

HIV released from cell

Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections. . . . → Read More: Engineered Immune, Stem Cells Studied for HIV Cure

Covid-19 Antibody Therapy Trial Underway

SARS-Cov-2 viruses

A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles. . . . → Read More: Covid-19 Antibody Therapy Trial Underway

NIH Funds Light-Aided Gene Therapy for Eye Disease

Eye measurements

A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received an NIH grant to advance its technology. . . . → Read More: NIH Funds Light-Aided Gene Therapy for Eye Disease

Covid-19 Vaccine Generates Immune Response

Syrine ingloved hand

First results from a clinical trial testing a vaccine to protect against Covid-19 infections show the vaccine produces an immune response in healthy participants. . . . → Read More: Covid-19 Vaccine Generates Immune Response

Biotech Gains Antibody Discovery, Manufacturing Funds

Global Covid-19

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds

NIH Opens Covid-19 Diagnostic Test Challenge

National Institutes of Health began a competition for new diagnostic tests that can better determine the extent of Covid-19 infections in the U.S. . . . → Read More: NIH Opens Covid-19 Diagnostic Test Challenge

BARDA Chief Removed for “Politics and Cronyism”

Rick Bright

The director of the federal agency protecting against pandemics says he was removed for refusing to endorse President Trump’s preferred Covid-19 treatment. . . . → Read More: BARDA Chief Removed for “Politics and Cronyism”

Moderna Gains $483M for Covid-19 Vaccine

SARS-Cov-2 virus

A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials. . . . → Read More: Moderna Gains $483M for Covid-19 Vaccine

Five Covid-19 Vaccines in Clinical Trials

Coronavirus face mask

A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage. . . . → Read More: Five Covid-19 Vaccines in Clinical Trials